ArticleCell death & disease2025

Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer.

Hongyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.